Although most recurrent PCa tumors are castrate-resistant, AR expression and function are maintained in advanced disease [6,7] and the growth of ablation-resistant PCa cells remains AR dependent as exemplified by the following three lines of evidence. This evidence concerns the gene AR and posterior cortical atrophy.